Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026)

Alto Neuroscience's (ANRO) quarterly Other Non-Current Assets came in at $500000.0 in Q1 2026, little changed year-on-year from $500000.0 in Q1 2025, and up 47.93% quarter-over-quarter from $338000.0 in Q4 2025.

Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026) Analysis & Trends

Alto Neuroscience has disclosed Other Non-Current Assets across 3 years of filings, most recently posting $500000.0 for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $500000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $500000.0 (changed 0.0% YoY), and the FY2025 annual result was $338000.0, down 32.4% from the prior year.
  • Other Non-Current Assets came in at $500000.0 for Q1 2026 at Alto Neuroscience, up from $338000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $570000.0 in Q2 2025 to a low of $4000.0 in Q2 2024.
  • The 3-year median for Other Non-Current Assets is $500000.0 (2024), against an average of $385555.6.
  • Peak annual rise in Other Non-Current Assets reached 14150.0% in 2025, while the deepest fall reached 32.4% in 2025.
  • Alto Neuroscience's Other Non-Current Assets stood at $500000.0 in 2024, then tumbled by 32.4% to $338000.0 in 2025, then jumped by 47.93% to $500000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $500000.0 (Q1 2026), $338000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 60,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Alto Neuroscience 643.06 Mn 379.30 Mn - 500,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Dec 31, 2025 338,000.00
Sep 30, 2025 500,000.00
Jun 30, 2025 570,000.00
Mar 31, 2025 500,000.00
Dec 31, 2024 500,000.00
Sep 30, 2024 500,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 58,000.00